Cybin Files Patent Application In Support Of Ongoing Drug Candidate Programs
Cybin Inc. (NEO:CYBN) (NYSE:CYBN) ("Cybin" or the "Company"), a biotechnology company focused on progressing psychedelic therapeutics, today announced that it has filed a new non-provisional